骨重建失衡导致骨质疏松发生的作用机制及其药(7)

[2] PARFITT structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical Tissue Int.1984;36 Suppl 1:S123-128.

[3] 周丕琪,沈霖,杜靖远,等.绝经后骨质疏松症与血清IL-6,TNF-α浓度关系的临床研究[J].中国骨质疏松杂志,2001,7(1):5-7+12.

[4] ANARGYROU K,FOTIOU D,VASSILAKOPOULOS TP,et al.Low bone mineral density and high bone turnover in patients with Non- Hodgkin's Lymphoma (NHL) who receive frontline therapy: results of a multicenter prospective ;3(6):e303.

[5] 林雅静,卢玉燕,王燕.骨吸收抑制剂在骨质疏松治疗中的合理用药分析[J].中国医药科学,2019,9(21):74-77.

[6] RAGHUVANSHI A,KUMAR A,TYAGI AM,et : A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic rats.Mol Cell ;448:41-54.

[7] SEEMAN E,DELMAS PD.Bone quality--the material and structural basis of bone strength and Engl J Med.2006;354(21):2250-2261.

[8] MAERZ T,KURDZIEL M,NEWTON MD,et and epiphyseal bone remodeling following surgical transection and noninvasive rupture of the anterior cruciate ligament as models of post-traumatic ;24(4): 698-708.

[9] BUENZLI PR,PIVONKA P,SMITH DW.Bone refilling in cortical basic multicellular units: insights into tetracycline double labelling from a computational Model ;13(1):185-203.

[10] HATTNER R,EPKER BN,FROST sequential mode of control of changes in cell behaviour in adult bone ;206(983):489-490.

[11] BUENZLI PR,PIVONKA P,SMITH structure of cell distribution in cortical bone multicellular units: a mathematical ;48(4):918-926.

[12] SRINIVASAN K,MIJARES DQ,JANAL MN,et al.In vivo efficacy of calcium phosphate-based synthetic-bone-mineral on bone loss resulting from estrogen and mineral Biomed Mater Res B Appl ;108(5):1868-1878.

[13] ANDERSEN TL,SONDERGAARD TE,SKORZYNSKA KE,et al.A physical mechanism for coupling bone resorption and formation in adult human bone.Am J ;174(1):239-247.

[14] NAKATOH S.Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density ;3(1): 45-52.

[15] HINTON PS,ROLLESTON A,REHRER NJ,et al.Bone formation is increased to a greater extent than bone resorption during a cycling stage Physiol Nutr ;35(3):344-349.

[16] HEANEY RP.The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change.J Bone Miner Res.1994;9(10):1515-1523.

[17] 胡渊博,王乐莎,蒋蕾,等.在细胞水平上调控骨重建的相关研究进展 [J].生物医学工程学杂志,2017,34(3):471-479.

[18] ARTHUR A,NGUYEN TM,PATON S,et al.The osteoprogenitor- specific loss of ephrinB1 results in an osteoporotic phenotype affecting the balance between bone formation and Rep.2018;8(1):.

[19] ARAI N,OHYA K,KASUGAI S,et of bone sialoprotein mRNA during bone formation and resorption induced by colchicine in rat tibial bone marrow cavity.J Bone Miner Res.1995;10(8):1209-1217.

[20] PARFITT (2): turnover is always higher in cancellous than in cortical ;30(6):807-809.

[21] TORNQUIST E,ISAKSSON H,TURUNEN of cortical bone during maturation and growth in Bone Miner

[22] 周灵通,黄凯,宋敏,等.Notch信号通路在骨重建过程中的双向调节作用[J].中国骨质疏松杂志,2019,25(7):1015-1020.

[23] LIPS P,COURPRON P,MEUNIER PJ.Mean wall thickness of trabecular bone packets in the human iliac crest: changes with Tissue Res.1978;26(1):13-17.

[24] ZEBAZE RM,GHASEM-ZADEH A,BOHTE A,et remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional ;375(9727): 1729-1736.

[25] MANOLAGAS SC.Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of Rev.2000;21(2):115-137.

[26] SKEDROS JG,KNIGHT AN,CLARK GC,et of Haversian canal surface area to secondary osteon bone volume in ribs and limb bones.Am J Phys ;151(2): 230-244.

[27] SCHAFFLER MB,BURR DB,FREDERICKSON of the osteonal cement line in human Rec.1987;217(3):223-228.

[28] 张向阳,梁朝革,唐献忠,等.骨质疏松患者股骨头不同区域骨结构与生物力学分析[J].医用生物力学,2017,32(1):77-82.

[29] ABTAHI S,BURDEN AM,GEUSENS P,et al.The association of oral bisphosphonate use with mortality risk following a major osteoporotic fracture in the united kingdom: population-based cohort study.J Am Med Dir : S1525-8610(19)-9.

[30] BARON R,FERRARI S,RUSSELL and bisphosphonates: different mechanisms of action and ;48(4):677-692.

[31] 陈武桂,孙靖,李松涛,等.通过骨基质表面培养板检测RANKL诱导破骨细胞骨侵蚀能力[J].中国骨质疏松杂志,2020,26(2):162-165.

[32] SEEMAN E,DELMAS PD,HANLEY DA,et deterioration of cortical and trabecular bone: differing effects of denosumab and Bone Miner Res.2010;25(8):1886-1894.

[33] SMITH SY,RECKER RR,HANNAN M,et intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus ;32(1):45-55.

文章来源：《力学季刊》 网址: http://www.lxjkzz.cn/qikandaodu/2021/0208/335.html